Press Releases

INDIANAPOLIS, May 6, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts – a strategic location that will help attract top scientists and bioengineers,...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, in Las Vegas. Doug Manion, head, Specialty Development, will make a formal presentation about the...

INDIANAPOLIS, May 4, 2015 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2015 of $0.50 per share on outstanding common stock. The...

Application includes CheckMate -066, a clinical trial of Opdivo vs. dacarbazine chemotherapy in patients who had not received prior therapy. CheckMate -066 marked the first time that a PD-1 immune checkpoint inhibitor demonstrated survival in a...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has agreed to sell €1.15 billion of senior unsecured notes: €575,000,000 in aggregate principal amount of 1.000% notes due 2025 and €575,000,000 in aggregate principal amount of 1.750% notes...

Reports Revenues of $4.0 Billion in the First Quarter Posts First Quarter GAAP and Non-GAAP EPS of $0.71 Achieves Key Data and Regulatory Milestones Across Portfolio Completes Strategic Transactions in Immuno-Oncology and Cardiovascular,...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has commenced a cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of specified series of its outstanding debt. Pursuant to the tender offer,...